Cochlear Ltd
ASX:COH
Cochlear Ltd
Revenue
Cochlear Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
148%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
Optiscan Imaging Ltd
ASX:OIL
|
Revenue
AU$1.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
34%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Cochlear Ltd's Revenue?
Revenue
2.1B
AUD
Based on the financial report for Dec 31, 2023, Cochlear Ltd's Revenue amounts to 2.1B AUD.
What is Cochlear Ltd's Revenue growth rate?
Revenue CAGR 10Y
11%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Cochlear Ltd have been 18% over the past three years , 9% over the past five years , and 11% over the past ten years .